187 related articles for article (PubMed ID: 30918221)
1. Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease - Post Hoc Analysis of the FMD-J Study A.
Kajikawa M; Maruhashi T; Kishimoto S; Matsui S; Hashimoto H; Takaeko Y; Yusoff FM; Kihara Y; Chayama K; Goto C; Noma K; Nakashima A; Tomiyama H; Takase B; Kohro T; Suzuki T; Ishizu T; Ueda S; Yamazaki T; Furumoto T; Kario K; Inoue T; Koba S; Watanabe K; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Ikeda H; Yamashina A; Higashi Y
Circ J; 2019 Apr; 83(5):1064-1071. PubMed ID: 30918221
[TBL] [Abstract][Full Text] [Related]
2. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
Toth PP; Philip S; Hull M; Granowitz C
Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
[TBL] [Abstract][Full Text] [Related]
3. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
4. Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.
Puri R; Nissen SE; Shao M; Elshazly MB; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2220-2228. PubMed ID: 27515380
[TBL] [Abstract][Full Text] [Related]
5. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial).
Nelson AJ; Navar AM; Mulder H; Wojdyla D; Philip S; Granowitz C; Peterson ED; Pagidipati NJ
Am J Cardiol; 2020 Oct; 132():36-43. PubMed ID: 32773223
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
[TBL] [Abstract][Full Text] [Related]
7. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
Hsu CY; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Chou RH; Huang CY; Huang PH; Leu HB; Yin WH; Wu CC; Lin SJ; Chen JW
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1240-1252. PubMed ID: 30943772
[TBL] [Abstract][Full Text] [Related]
8. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
[TBL] [Abstract][Full Text] [Related]
9. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.
Mao Q; Zhou D; Li Y; Wang Y; Xu SC; Zhao XH
Dis Markers; 2019; 2019():6891537. PubMed ID: 31281548
[TBL] [Abstract][Full Text] [Related]
10. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
11. The triglyceride paradox in the mortality of coronary artery disease.
Xia TL; Li YM; Huang FY; Chai H; Huang BT; Li Q; Zhao ZG; Liao YB; Zuo ZL; Peng Y; Chen M; Huang DJ
Lipids Health Dis; 2019 Jan; 18(1):21. PubMed ID: 30670053
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
[TBL] [Abstract][Full Text] [Related]
14. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
[TBL] [Abstract][Full Text] [Related]
15. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.
Miller M; Seidler A; Moalemi A; Pearson TA
J Am Coll Cardiol; 1998 May; 31(6):1252-7. PubMed ID: 9581716
[TBL] [Abstract][Full Text] [Related]
16. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.
Wan K; Zhao J; Huang H; Zhang Q; Chen X; Zeng Z; Zhang L; Chen Y
PLoS One; 2015; 10(4):e0123521. PubMed ID: 25880982
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
18. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
[TBL] [Abstract][Full Text] [Related]
19. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
20. Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease.
De Rosa R; De Rosa S; Leistner D; Boeckel JN; Keller T; Fichtlscherer S; Dimmeler S; Zeiher AM
Am J Cardiol; 2017 Jul; 120(1):15-24. PubMed ID: 28511772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
